These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9040091)

  • 1. Radioimmunoassay of meterelin and pharmacokinetics after single injection and implant administration in dogs.
    Hudon E; Rondeau JJ; Lenaerts V; Würthrich P; Boutignon F; Deghenghi R; Marleau S; Yamaguchi N; Adam A; Ong H
    J Pharm Sci; 1997 Feb; 86(2):172-8. PubMed ID: 9040091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of [D-Trp6]-luteinizing hormone-releasing hormone: its application to animal pharmacokinetic studies after single injection and long-acting formulation administration.
    Ezan E; Drieu K; Chapelat M; Rougeot C; Dray F
    Regul Pept; 1986 Apr; 14(2):155-67. PubMed ID: 2940625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of the distribution and metabolism of the gonadotropin-releasing hormone (GnRH) agonist [D-Trp6,Des-Gly-NH2(10)]GnRH ethylamide in man.
    Candas B; Lacoste D; Normand M; Labrie F
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1046-54. PubMed ID: 2180974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for luteinizing hormone-releasing hormone (LHRH): its application to the measurement of LHRH in ovine and human plasma.
    Jonas HA; Burger HG; Cumming IA; Findlay JK; de Kretser DM
    Endocrinology; 1975 Feb; 96(2):384-93. PubMed ID: 1090433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of LH release and ovulation in the rabbit with inhibitory analogues of luteinizing hormone releasing hormone.
    Phelps CP; Coy DH; Schally AV; Sawyer CH
    Endocrinology; 1977 Jun; 100(6):1526-32. PubMed ID: 322998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model of the distribution and metabolism of a GnRH superagonist in dogs.
    Lacoste D; Candas B; Normand M; Labrie F
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E468-75. PubMed ID: 2180316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of RS-26306, a potent luteinizing hormone-releasing hormone antagonist, in monkeys and rats after single intravenous and subcutaneous administration.
    Chan RL; Hsieh SC; Haroldsen PE; Ho W; Nestor JJ
    Drug Metab Dispos; 1991; 19(5):858-64. PubMed ID: 1686228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH.
    Csernus VJ; Szende B; Groot K; Redding TW; Schally AV
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):111-8. PubMed ID: 2110458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs.
    Vickery BH; McRae GI; Bonasch H
    Prostate; 1982; 3(2):123-30. PubMed ID: 6178098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation in rat plasma of a direct radioimmunoassay for a luteinizing hormone-releasing hormone antagonist (BIM 21009).
    Ezan E; Drieu K; Moreau JP; Dray F
    J Immunoassay; 1990; 11(3):295-309. PubMed ID: 2229420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of Antarelix, a luteinizing hormone releasing-hormone antagonist, in plasma and its application for pharmacokinetic study in dogs.
    Sorensen S; Rondeau JJ; Lenaerts V; Boutignon F; Wüthrich P; Deghenghi R; Adam A; Ong H
    J Immunoassay; 1996 Aug; 17(3):205-26. PubMed ID: 8842981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.
    Roumi M; Lenaerts V; Boutignon F; Wuthrich P; Deghenghi R; Bellemare M; Adam A; Ong H
    Peptides; 1995; 16(7):1301-6. PubMed ID: 8545255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile follicle-stimulating hormone secretion is independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement of LHRH bioactivity in LHRH-immunoneutralized rats.
    Culler MD; Negro-Vilar A
    Endocrinology; 1987 May; 120(5):2011-21. PubMed ID: 2436893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
    Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
    J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.
    Erb K; Junge K; Pechstein B; Schneider E; Derendorf H; Hermann R
    J Clin Pharmacol; 2002 Sep; 42(9):995-1001. PubMed ID: 12211225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.